BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36910427)

  • 1. Unraveling the mechanism of action of cepharanthine for the treatment of novel coronavirus pneumonia (COVID-19) from the perspectives of systematic pharmacology.
    Sun F; Liu J; Tariq A; Wang Z; Wu Y; Li L
    Arab J Chem; 2023 Jun; 16(6):104722. PubMed ID: 36910427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissecting the molecular mechanism of cepharanthine against COVID-19, based on a network pharmacology strategy combined with RNA-sequencing analysis, molecular docking, and molecular dynamics simulation.
    Liu J; Sun T; Liu S; Liu J; Fang S; Tan S; Zeng Y; Zhang B; Li W
    Comput Biol Med; 2022 Dec; 151(Pt A):106298. PubMed ID: 36403355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Network pharmacology, molecular docking integrated surface plasmon resonance technology reveals the mechanism of Toujie Quwen Granules against coronavirus disease 2019 pneumonia.
    Ye M; Luo G; Ye D; She M; Sun N; Lu YJ; Zheng J
    Phytomedicine; 2021 May; 85():153401. PubMed ID: 33191068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cepharanthine: A Promising Old Drug against SARS-CoV-2.
    Fan H; He ST; Han P; Hong B; Liu K; Li M; Wang S; Tong Y
    Adv Biol (Weinh); 2022 Dec; 6(12):e2200148. PubMed ID: 35775953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The common regulatory pathway of COVID-19 and multiple inflammatory diseases and the molecular mechanism of cepharanthine in the treatment of COVID-19.
    Jiang P; Ye J; Jia M; Li X; Wei S; Li N
    Front Pharmacol; 2022; 13():960267. PubMed ID: 35935817
    [No Abstract]   [Full Text] [Related]  

  • 6. Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Huashi Baidu formula in the treatment of COVID-19.
    Tao Q; Du J; Li X; Zeng J; Tan B; Xu J; Lin W; Chen XL
    Drug Dev Ind Pharm; 2020 Aug; 46(8):1345-1353. PubMed ID: 32643448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential effect of Maxing Shigan decoction against coronavirus disease 2019 (COVID-19) revealed by network pharmacology and experimental verification.
    Li Y; Chu F; Li P; Johnson N; Li T; Wang Y; An R; Wu D; Chen J; Su Z; Gu X; Ding X
    J Ethnopharmacol; 2021 May; 271():113854. PubMed ID: 33513419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacological mechanism of Huashi Baidu Formula for the treatment of COVID-19 by combined network pharmacology and molecular docking.
    Cai Y; Zeng M; Chen YZ
    Ann Palliat Med; 2021 Apr; 10(4):3864-3895. PubMed ID: 33691446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of phytochemical compounds of
    Zhang M; Zhang X; Pei J; Guo B; Zhang G; Li M; Huang L
    Heliyon; 2023 Mar; 9(3):e14029. PubMed ID: 36911881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Traditional Chinese medicine network pharmacology study on exploring the mechanism of Xuebijing Injection in the treatment of coronavirus disease 2019.
    Xing Y; Hua YR; Shang J; Ge WH; Liao J
    Chin J Nat Med; 2020 Dec; 18(12):941-951. PubMed ID: 33357725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mechanism and active compounds of semen
    Wang Y; Gu W; Kui F; Gao F; Niu Y; Li W; Zhang Y; Guo Z; Du G
    Food Nutr Res; 2021; 65():. PubMed ID: 34908920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological Activity of Cepharanthine.
    Liu K; Hong B; Wang S; Lou F; You Y; Hu R; Shafqat A; Fan H; Tong Y
    Molecules; 2023 Jun; 28(13):. PubMed ID: 37446681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical composition and pharmacological mechanism of shenfu decoction in the treatment of novel coronavirus
    Li X; Lin H; Wang Q; Cui L; Luo H; Luo L
    Drug Dev Ind Pharm; 2020 Dec; 46(12):1947-1959. PubMed ID: 33054436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Silico Screening of Potential Chinese Herbal Medicine Against COVID-19 by Targeting SARS-CoV-2 3CLpro and Angiotensin Converting Enzyme II Using Molecular Docking.
    Gao LQ; Xu J; Chen SD
    Chin J Integr Med; 2020 Jul; 26(7):527-532. PubMed ID: 32632717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring potential mechanisms of Suhexiang Pill against COVID-19 based on network pharmacology and molecular docking.
    Li J; Huang Z; Lu S; Luo H; Tan Y; Ye P; Liu X; Wu Z; Wu C; Stalin A; Wang H; Liu Y; Shen L; Fan X; Zhang B; Yi J; Yao L; Xu Y; Wu J; Duan X
    Medicine (Baltimore); 2021 Dec; 100(51):e27112. PubMed ID: 34941025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Network analysis for elucidating the mechanisms of Shenfu injection in preventing and treating COVID-19 combined with heart failure.
    Zhou W; Chen Z; Fang Z; Xu D
    Comput Biol Med; 2022 Sep; 148():105845. PubMed ID: 35849948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The brief overview, antivirus and anti-SARS-CoV-2 activity, quantitative methods, and pharmacokinetics of cepharanthine: a potential small-molecule drug against COVID-19.
    Xia B; Zheng L; Li Y; Sun W; Liu Y; Li L; Pang J; Chen J; Li J; Cheng H
    Front Pharmacol; 2023; 14():1098972. PubMed ID: 37583901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of mechanisms of Shenhuang Granule in treating severe COVID-19 based on network pharmacology and molecular docking.
    Xu XR; Zhang W; Wu XX; Yang HQ; Sun YT; Pu YT; Wang B; Peng W; Sun LH; Guo Q; Zhou S; Fang BJ
    J Integr Med; 2022 Nov; 20(6):561-574. PubMed ID: 35934629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioactive Components of
    Yuan H; Liu L; Zhou J; Zhang T; Daily JW; Park S
    J Med Food; 2022 Apr; 25(4):355-366. PubMed ID: 35438554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposing Ayush-64 for COVID-19: A Computational Study Based on Network Pharmacology and Molecular Docking.
    K C M; K A AN
    Comb Chem High Throughput Screen; 2022; 25(12):2089-2102. PubMed ID: 35142268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.